Dodos Konstantinos, Kalamara Vasileia Tsampika, Georgakopoulou Vasiliki Epameinondas, Kavoura Paraskevi
Laboratory of Physiology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Acta Med Litu. 2025;32(1):210-211. doi: 10.15388/Amed.2025.32.1.21. Epub 2025 Feb 18.
Nodal Marginal Zone Lymphoma (NMZL) is a rare, indolent subtype of B-cell non-Hodgkin lymphoma. This case report presents a 67-year-old female diagnosed with NMZL, which had transformed into Diffuse Large B-cell Lymphoma (DLBCL) at the time of diagnosis. The patient's initial presentation involved a dry cough and pleural effusion, a symptom rarely reported in NMZL cases. Diagnostic procedures, including cytology and immunohistochemistry, confirmed the presence of monoclonal B lymphocytes and identified markers consistent with NMZL transformation to DLBCL. The findings highlight the diagnostic challenges associated with NMZL due to the lack of specific immunohistochemical markers, emphasizing the need for histopathological analysis to distinguish NMZL from other lymphomas, such as follicular lymphoma. This case underscores the importance of early detection and differentiation in lymphomas presenting with pleural effusion, as transformation to aggressive forms like DLBCL significantly impacts the prognosis and treatment approaches. Despite the rarity of transformation at diagnosis, clinicians must consider it in NMZL cases with atypical presentations.
结外边缘区淋巴瘤(NMZL)是一种罕见的惰性B细胞非霍奇金淋巴瘤亚型。本病例报告介绍了一名67岁女性,被诊断为NMZL,在诊断时已转化为弥漫性大B细胞淋巴瘤(DLBCL)。患者最初的表现为干咳和胸腔积液,这是NMZL病例中很少报道的症状。包括细胞学和免疫组织化学在内的诊断程序证实了单克隆B淋巴细胞的存在,并确定了与NMZL转化为DLBCL一致的标志物。这些发现突出了由于缺乏特异性免疫组织化学标志物而与NMZL相关的诊断挑战,强调了进行组织病理学分析以将NMZL与其他淋巴瘤(如滤泡性淋巴瘤)区分开来的必要性。本病例强调了在出现胸腔积液的淋巴瘤中早期检测和鉴别诊断的重要性,因为转化为DLBCL等侵袭性形式会显著影响预后和治疗方法。尽管诊断时转化罕见,但临床医生在NMZL非典型表现的病例中必须考虑到这一点。